Research Overview
ACE-031 is an ActRIIB (activin receptor type IIB) ligand trap studied in research models involving myostatin signaling, skeletal muscle physiology, tissue remodeling, growth factor biology, and body composition.
By binding multiple ligands within the ActRIIB pathway, ACE-031 enables researchers to investigate biological mechanisms that regulate muscle development, tissue homeostasis, and anabolic signaling. Its distinct mechanism has established it as an important research tool for studying pathways that influence musculoskeletal biology and cellular growth regulation.
Lyophilized Vial Format
Precision-manufactured and lyophilized for stability, this research-grade compound is produced to support reproducible laboratory workflows requiring accurate preparation, controlled storage, and consistent experimental performance.
Why Researchers Study ACE-031
The ActRIIB signaling pathway serves as a central regulator of skeletal muscle development and tissue remodeling through interactions with proteins including myostatin and activins. Modulation of this pathway has become an important area of investigation for researchers seeking to better understand the biological processes that govern muscle growth and regenerative signaling.
ACE-031 provides a valuable tool for exploring these mechanisms by sequestering ligands that activate the ActRIIB receptor. Ongoing research continues to examine its role across experimental models involving muscle physiology, growth factor signaling, and body composition.
Research Applications
Researchers commonly utilize ACE-031 in laboratory investigations involving:
- ActRIIB signaling
- Myostatin biology
- Activin signaling pathways
- Skeletal muscle physiology
- Muscle growth regulation
- Tissue remodeling
- Growth factor biology
- Regenerative research
- Cellular anabolic signaling
- Body composition models
